Primary anaplastic ganglioglioma with a small-cell glioblastoma component

Clinical Neuropathology

Volumn 27, Issue 2, 2008, Pages 91-95

  Schittenhelm, J ^a   Reifenberger, G ^b   Ritz, R ^a   Nagele T ^a   Weller, M ^a   Pantazis, G ^a   Capper, D ^a   Beschomer, R ^a   Meyermann, R ^a   Mittelbronn, M ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Anaplastic ganglioglioma; Glioneuronal tumor; Malignant progression; Small cell glioblastoma

Indexed keywords

ETIRACETAM;

AGED; ANAMNESIS; ANAPLASTIC CARCINOMA; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; GLIOBLASTOMA; GLIOMA; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; LABORATORY TEST; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION DOSE; SEIZURE; SMALL CELL CARCINOMA;

EID: 41149095199     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: 10.5414/npp27091     Document Type: Article

References (28)

1. Allegranza A, Pileri S, Frank G, Ferracini R. Cerebral ganglioglioma with anaplastic oligodendroglial component. Histopathology. 1990; 17: 439-441.
2. Blúmcke I, Wiestler OD. Gangliogliomas: an intriguing tumor entity associated with focal epilepsies. J Neuropathol Exp Neurol. 2002; 61: 575-584.
3. Dash RC, Provenzale JM, McComb RD, Perry DA, Longee DC, McLendon RE. Malignant supratentorial ganglioglioma (ganglion cell-giant cell glioblastoma): a case report and review of the literature. Arch Pathol Lab Med. 1999; 123: 342-345.
4. Di Patre PL, Payer M, Brunea M, Delavelle J, De Tribolet N, Pizzolato G. Malignant transformation of a spinal cord ganglioglioma - case report and review of the literature. Clin Neuropathol. 2004; 23: 298-303.
5. Edgar MA, Rosenblum MK. Mixed glioneuronal tumors: recently described entities. Arch Pathol Lab Med. 2007; 131: 228-233.
6. Haddad SF, Moore SA, Menezes AH, Van Gilder JC. Ganglioglioma: 13 years of experience. Neurosurgery. 1992; 31: 171-178.
7. Hayashi Y, Iwato M, Hasegawa M, Tachibana O, von Deimling A, Yamashita J. Malignant transformation of a gangliocytoma/ganglioglioma into a glioblastoma multiforme: a molecular-genetic analysis. J Neurosurg. 2001; 95: 138-142.
8. Im SH, Chung CK, Cho BK, Wang KC, Yu IK, Song IC, Cheon GJ, Lee DS, Kim NR, Chi JG. Intracranial ganglioglioma: preoperative characteristics and oncologic outcome after surgery. J Neurooncol. 2002; 59: 173-183.
9. Jallo GI, Freed D, Epstein FJ. Spinal cord gangliogliomas: a review of 56 patients. J Neurooncol. 2004; 68: 71-77.
10. Kernohan JW, Learmonth JR, Doyle JB. Neuroblastomas and gangliocytomas of the central nervous system. Brain. 1932; 55: 287-310.
11. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. Pathology and genetics of tumors of nervous system. Lyon: IARC Press; 2007. p. 103-105.
12. Lang FF, Epstein FJ, Ransohoff J, Allen JC, Wisoff J, Abbott IR, Miller DC. Central nervous system gangliogliomas. Part 2: Clinical outcome. J Neurosurg. 1993; 79: 867-873.
13. Luyken C, Blümcke I, Fimmers R, Urbach H, Wiestler OD, Schramm J. Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer. 2004; 101: 146-155.
14. Matsuzaki K, Uno M, Kageji T, Hirose T, Nagahiro S. Anaplastic ganglioglioma of the cerebellopontine angle. Neurol Med Chir. 2005; 45: 591-595.
15. Mekni A, Chelly I, Haouet S, Zitouna M, Kchir N. Malignant cerebellar ganglioglioma. A case report and review of the literature. Neurochirurgie. 2006; 52: 119-122.
16. Mittelbronn M, Schittenhelm J, Lemke D, Ritz R, Nägele T, Weller M, Meyermann R, Beschorner R. Low-grade ganglioglioma rapidly progressing to a WHO Grade IV tumor showing malignant transformation in both astroglial and neuronal cell components. Neuropathology. 2007; 27: 463-467.
17. Perkins OC. Ganglioglioma. Arch Pathol Lab Med. 1926; 2: 11-17.
18. Rodriguez FJ, Scheithauer BW, Port JD. Unusual malignant glioneuronal tumors of the cerebrum of adults: a clinicopathologic study of three cases. Acta Neuropathol. 2006; 112: 727-737.
19. Rumana CS, Valadka AB, Contant CF. Prognostic factors in supratentorial ganglioglioma. Acta Neurochir. 1999; 141: 63-68.
20. Rumana CS, Valadka AB. Radiation therapy and malignant degeneration of benign supratentorial gangliogliomas. Neurosurgery. 1998; 42: 1038-1043.
21. Sasaki A, Hirato J, Nakazato Y, Tamura M, Kadowaki H. Recurrent anaplastic ganglioglioma: pathological characterization of tumor cells. J Neurosurg. 1996; 84: 1055-1059.
22. Selch MT, Goy BW, Lee SP, El-Sadin S, Kincaid P, Park SH, Withers HR. Gangliogliomas: experience with 34 patients and review of the literature. Am J Clin Oncol. 1998; 21: 557-564.
23. Shibahara J, Fukayama M. Secondary glioblastoma with advanced neuronal immunophenotype. Virchows Arch. 2005; 447: 665-668.
24. Squire JA, Arab S, Marrano P, Bayani J, Karaskova J, Taylor M, Becker L, Rutka J, Zielenska M. Molecular-cytogenetic analysis of glial tumors using spectral karyotyping and comparative genomic hybridization. Mol Diagn. 2001; 6: 93-108.
25. Suzuki H, Otsuki T, Iwasaki Y, Katakura R, Asano H, Tadokoro M, Suzuki Y, Tezuka F, Takei H. Anaplastic ganglioglioma with sarcomatous component: an immunohistochemical study and molecular analysis of p53 tumor suppressor gene. Neuropathology. 2002; 22: 40-47.
26. Wacker MR, Cogen PH, Etzell JE, Daneshvar L, Davis RL, Prados MD. Diffuse leptomeningeal involvement by a ganglioglioma in a child. J Neurosurg. 1992; 77: 302-306.
27. Wolf HK, Muller MB, Spanle M, Zentner J, Schramm J, Wiestler OD. Ganglioglioma: a detailed histopathological and immunohistochemical analysis of 61 cases. Acta Neuropathol. 1994; 88: 166-173.
28. Zentner J, Wolf HK, Ostertun B, Hufnagel A, Campos MG, Solymosi L, Schramm J. Gangliogliomas: clinical, radiological, and histopathological findings in 51 patients. J Neurol Neurosurg Psychiatry. 1994; 57: 1497-1502.